Citi upgraded Afya (AFYA) to Neutral from Sell with a price target of $14, down from $16. The firm says the company’s risks are better priced into the shares following Afya’s underperformance year-to-date relative to its Brazilian peers. The firm cites valuation for the upgrade despite dropping the target on reduced earnings assumptions.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFYA: